아세트산 칼슘

용도

• Hyperphosphatemia associated with chronic renal failure
• Hyperphosphatemia in CKD
• Hyperphosphatemia associated with chronic renal failure
• Hyperphosphatemia in CKD

투여 방법

가능한 부작용

• Hypercalcemia
• Gastrointestinal intolerance (nausea)

주의사항 및 금기

• Pre-existing hypercalcemia
• > **Warning:** Do not use in patients with pre-existing hypercalcemia. - **Ca × P Product:** Use with extreme caution if the serum calcium and phosphorus product exceeds 60 due to the risk of metastatic soft tissue mineralization. - **Concurrent Calcitriol:** The concurrent use of calcium-based binders and calcitriol is controversial; some consider it contraindicated, while others require intensified monitoring for hypercalcemia. - **Monitoring:** Adequate monitoring of serum ionized calcium and phosphorus is strictly required.

약물 상호작용

• Calcitriol: May lead to hypercalcemia; if used concomitantly, intensified monitoring for hypercalcemia is mandatory.
• Digoxin: Not recommended; hypercalcemia induced by calcium acetate may cause serious arrhythmias in patients on digoxin.
• Fluoroquinolones: Oral calcium can reduce the absorption of fluoroquinolones. Separate dosages by at least two hours.
• Tetracyclines: Oral calcium can reduce the absorption of tetracyclines. Separate dosages by at least two hours.
• Levothyroxine: Decreased absorption of levothyroxine

자주 묻는 질문